tiprankstipranks
Trending News
More News >
Qualigen Therapeutics Inc (QLGN)
:QLGN
US Market
Advertisement

Qualigen Therapeutics (QLGN) Financial Statements

Compare
662 Followers

Qualigen Therapeutics Financial Overview

Qualigen Therapeutics's market cap is currently $4.82M. The company's EPS TTM is $-55.297; its P/E ratio is ―; Qualigen Therapeutics is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 5.20M$ 4.98M$ 5.65M$ 4.31M
Gross Profit$ 0.00$ -4.50K$ 680.80K$ 1.32M$ -2.88M
Operating Income$ -5.76M$ -11.30M$ -17.94M$ -22.66M$ -11.30M
EBITDA$ -5.24M$ -11.30M$ -13.84M$ -22.66M$ -11.16M
Net Income$ -6.16M$ -13.42M$ -21.03M$ -17.90M$ -20.42M
Balance Sheet
Cash & Short-Term Investments$ 1.17M$ 401.80K$ 7.03M$ 17.54M$ 23.98M
Total Assets$ 4.69M$ 2.03M$ 19.08M$ 22.84M$ 29.13M
Total Debt$ 0.00$ 1.30M$ 2.71M$ 1.68M$ 375.56K
Net Debt$ -1.17M$ 897.41K$ -4.33M$ -15.86M$ -23.60M
Total Liabilities$ 2.01M$ 4.14M$ 10.32M$ 6.27M$ 10.83M
Stockholders' Equity$ 2.68M$ -2.10M$ 7.24M$ 16.56M$ 18.29M
Cash Flow
Free Cash Flow$ -6.33M$ -10.30M$ -13.57M$ -14.87M$ -9.97M
Operating Cash Flow$ -6.33M$ -10.30M$ -13.25M$ -14.73M$ -9.76M
Investing Cash Flow$ -1.91M$ 4.22M$ -183.76K$ -141.36K$ -160.56K
Financing Cash Flow$ 9.01M$ -550.00K$ 2.91M$ 8.43M$ 33.76M
Currency in USD

Qualigen Therapeutics Earnings and Revenue History

Qualigen Therapeutics Debt to Assets

Qualigen Therapeutics Cash Flow

Qualigen Therapeutics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis